243 related articles for article (PubMed ID: 15718241)
1. Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism.
Cole SL; Grudzien A; Manhart IO; Kelly BL; Oakley H; Vassar R
J Biol Chem; 2005 May; 280(19):18755-70. PubMed ID: 15718241
[TBL] [Abstract][Full Text] [Related]
2. Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms.
Parsons RB; Price GC; Farrant JK; Subramaniam D; Adeagbo-Sheikh J; Austen BM
Biochem J; 2006 Oct; 399(2):205-14. PubMed ID: 16803455
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
[TBL] [Abstract][Full Text] [Related]
4. Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons.
Hosaka A; Araki W; Oda A; Tomidokoro Y; Tamaoka A
Neurochem Res; 2013 Mar; 38(3):589-600. PubMed ID: 23269484
[TBL] [Abstract][Full Text] [Related]
5. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
[TBL] [Abstract][Full Text] [Related]
6. The regulation of beta-secretase by cholesterol and statins in Alzheimer's disease.
Sidera C; Parsons R; Austen B
J Neurol Sci; 2005 Mar; 229-230():269-73. PubMed ID: 15760650
[TBL] [Abstract][Full Text] [Related]
7. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.
Kojro E; Füger P; Prinzen C; Kanarek AM; Rat D; Endres K; Fahrenholz F; Postina R
J Alzheimers Dis; 2010; 20(4):1215-31. PubMed ID: 20413873
[TBL] [Abstract][Full Text] [Related]
8. Effects of cholesterol transport inhibitor U18666A on APP metabolism in rat primary astrocytes.
Yang H; Wang Y; Kar S
Glia; 2017 Nov; 65(11):1728-1743. PubMed ID: 28722194
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization.
Langness VF; van der Kant R; Das U; Wang L; Chaves RDS; Goldstein LSB
Mol Biol Cell; 2021 Feb; 32(3):247-259. PubMed ID: 33296223
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer's Disease.
Sathya M; Moorthi P; Premkumar P; Kandasamy M; Jayachandran KS; Anusuyadevi M
J Alzheimers Dis; 2017; 60(s1):S3-S23. PubMed ID: 28059793
[TBL] [Abstract][Full Text] [Related]
11. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
12. Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma.
Zhou Y; Suram A; Venugopal C; Prakasam A; Lin S; Su Y; Li B; Paul SM; Sambamurti K
FASEB J; 2008 Jan; 22(1):47-54. PubMed ID: 17666454
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein.
Carey RM; Balcz BA; Lopez-Coviella I; Slack BE
BMC Cell Biol; 2005 Aug; 6():30. PubMed ID: 16095541
[TBL] [Abstract][Full Text] [Related]
14. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.
Ehehalt R; Keller P; Haass C; Thiele C; Simons K
J Cell Biol; 2003 Jan; 160(1):113-23. PubMed ID: 12515826
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells.
Runz H; Rietdorf J; Tomic I; de Bernard M; Beyreuther K; Pepperkok R; Hartmann T
J Neurosci; 2002 Mar; 22(5):1679-89. PubMed ID: 11880497
[TBL] [Abstract][Full Text] [Related]
16. The Alzheimer beta-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells.
Kuentzel SL; Ali SM; Altman RA; Greenberg BD; Raub TJ
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):367-78. PubMed ID: 8240235
[TBL] [Abstract][Full Text] [Related]
17. Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.
Shinohara M; Sato N; Kurinami H; Takeuchi D; Takeda S; Shimamura M; Yamashita T; Uchiyama Y; Rakugi H; Morishita R
J Biol Chem; 2010 Jul; 285(29):22091-102. PubMed ID: 20472556
[TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein.
Neumann S; Schöbel S; Jäger S; Trautwein A; Haass C; Pietrzik CU; Lichtenthaler SF
J Biol Chem; 2006 Mar; 281(11):7583-94. PubMed ID: 16344553
[TBL] [Abstract][Full Text] [Related]
19. Can statins put the brakes on Alzheimer's disease?
Whitfield JF
Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
[TBL] [Abstract][Full Text] [Related]
20. High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease.
Rockenstein E; Mante M; Alford M; Adame A; Crews L; Hashimoto M; Esposito L; Mucke L; Masliah E
J Biol Chem; 2005 Sep; 280(38):32957-67. PubMed ID: 16027115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
